Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America
Benedikt Fischer, Caroline O’Keefe-Markman, Angelica Lee, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data
Sameer Imtiaz, Frishta Nafeh, Cayley Russell, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 72
Rising syphilis rates in Canada, 2011–2020
Joséphine Aho, Cassandra Lybeck, Ashorkor Tetteh, et al.
Canada Communicable Disease Report (2022) Vol. 47, Iss. 2-3, pp. 52-60
Open Access | Times Cited: 49
A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery
Samuel F. Acuff, Jennifer D. Ellis, Jill A. Rabinowitz, et al.
Drug and Alcohol Dependence (2024) Vol. 256, pp. 111092-111092
Closed Access | Times Cited: 6
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA)
Sean T. Allen, Molly C. Reid, Kristin E. Schneider, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD)
Akshata Y. Patne, Subhra Mohapatra, Shyam S. Mohapatra
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Open Access
Minority Stress and Stimulant Use among US Adult Sexual Minority Men: A Systematic Review
Michael Miller-Perusse, Keith J. Horvath, Jessica L. Montoya, et al.
Drug and Alcohol Dependence Reports (2025), pp. 100333-100333
Open Access
Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study
Shannon Brumbaugh, Wen‐Jan Tuan, Alyssa Scott, et al.
EClinicalMedicine (2022) Vol. 50, pp. 101524-101524
Open Access | Times Cited: 20
A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder
Michael V. Heinz, George Price, A P Singh, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209685-209685
Closed Access
Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration
Heather Palis, Wen Qi Gan, Chloé G. Xavier, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243653-e2243653
Open Access | Times Cited: 17
Drug overdose death rates in different countries: Who should be alarmed?
John Snowdon
Australasian Psychiatry (2022) Vol. 30, Iss. 1, pp. 26-30
Closed Access | Times Cited: 16
Associations between short-term ambient temperature exposure and emergency department visits for amphetamine, cocaine, and opioid use in California from 2005 to 2019
Howard H. Chang, H Zhang, Amanda D. Latimore, et al.
Environment International (2023) Vol. 181, pp. 108233-108233
Open Access | Times Cited: 10
Presentation and Outcomes of Adults With Overdose-Related Out-of-Hospital Cardiac Arrest
Vidhushei Yogeswaran, Christopher Drucker, Kosuke Kume, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2341921-e2341921
Open Access | Times Cited: 9
Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse
Justin C. Strickland, Cassandra D. Gipson, Kelly E. Dunn
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14
The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment
Lillian Lourenço, Marian Kelly, Jill Tarasuk, et al.
Canada Communicable Disease Report (2021) Vol. 47, Iss. 12, pp. 505-514
Open Access | Times Cited: 19
Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016–2019
Riley D. Shearer, Nathan D. Shippee, Beth A Virnig, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 10, pp. 100219-100219
Open Access | Times Cited: 2
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
Dimitri Daldegan‐Bueno, Lucas Oliveira Maia, Michelle Glass, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1211-1230
Open Access | Times Cited: 13
Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study
Zishan Cui, Kanna Hayashi, Paxton Bach, et al.
Drug and Alcohol Dependence (2022) Vol. 240, pp. 109624-109624
Open Access | Times Cited: 9
Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study
Heather Palis, Bin Zhao, Pam Young, et al.
Substance Abuse Treatment Prevention and Policy (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Gender, sexual orientation identity, and initiation of amphetamine injecting among people who inject drugs: Examination of an expanding drug era in Montreal, Canada, 2011–19
Stine Bordier Høj, Nanor Minoyan, Geng Zang, et al.
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110956-110956
Open Access | Times Cited: 4
Harm reduction in undergraduate and graduate medical education: a systematic scoping review
Kelsey Smith, Nina K. Shah, Abby Adamczyk, et al.
BMC Medical Education (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020–August 2021
Jay Chandra, Marie‐Laure Charpignon, Anushka Bhaskar, et al.
American Journal of Public Health (2024) Vol. 114, Iss. 6, pp. 599-609
Open Access | Times Cited: 1
Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization
Riley D. Shearer, Gavin Bart, Timothy J. Beebe, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 167, pp. 209505-209505
Closed Access | Times Cited: 1
Using state opioid response grant funding to disseminate contingency management for substance use disorder treatment in Indiana
Michael P. Smoker, Jeremiah Weinstock, Brigid R. Marriott, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 169, pp. 209589-209589
Closed Access | Times Cited: 1
Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis
John Snowdon, Namkee G. Choi
International Journal of Mental Health and Addiction (2022) Vol. 22, Iss. 3, pp. 1394-1412
Open Access | Times Cited: 7
The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis
Zishan Cui, Mohammad Karamouzian, Michael R. Law, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 6, pp. 4004-4020
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top